Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer C Germain, S Gnjatic, F Tamzalit, S Knockaert, R Remark, J Goc, ... American journal of respiratory and critical care medicine 189 (7), 832-844, 2014 | 664 | 2014 |
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura M Debré, C Griscelli, MC Bonnet, E Carosella, N Philippe, P Reinert, ... The Lancet 342 (8877), 945-949, 1993 | 395 | 1993 |
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects M Allez, K Karmiris, E Louis, G Van Assche, S Ben-Horin, A Klein, ... Journal of Crohn's and Colitis 4 (4), 355-366, 2010 | 371 | 2010 |
Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry N Jamin, P Dumas, J Moncuit, WH Fridman, JL Teillaud, GL Carr, ... Proceedings of the National Academy of Sciences 95 (9), 4837-4840, 1998 | 321 | 1998 |
Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines L Pricop, P Redecha, JL Teillaud, J Frey, WH Fridman, C Sautes-Fridman, ... The Journal of Immunology 166 (1), 531-537, 2001 | 303 | 2001 |
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response R Abès, E Gélizé, WH Fridman, JL Teillaud Blood, The Journal of the American Society of Hematology 116 (6), 926-934, 2010 | 236 | 2010 |
Regulated expression and inhibitory function of FcγRIIb in human monocytic cells S Tridandapani, K Siefker, JE Carter, MD Wewers, CL Anderson, ... Journal of Biological Chemistry 277 (7), 5082-5089, 2002 | 197 | 2002 |
p53 antibodies in patients with various types of cancer: assay, identification, and characterization. R Lubin, B Schlichtholz, JL Teillaud, E Garay, A Bussel, CP Wild Clinical cancer research: an official journal of the American Association …, 1995 | 182 | 1995 |
Structural bases of Fcγ receptor functions WH Fridman, C Bonnerot, M Daeron, S Amigorena, JL Teillaud, C Sautes Immunological reviews 125 (1), 49-76, 1992 | 177 | 1992 |
Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression O Cochet, M Kenigsberg, I Delumeau, A Virone-Oddos, MC Multon, ... Cancer research 58 (6), 1170-1176, 1998 | 176 | 1998 |
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques C Moog, N Dereuddre-Bosquet, JL Teillaud, ME Biedma, V Holl, ... Mucosal immunology 7 (1), 46-56, 2014 | 174 | 2014 |
Impact of glycosylation on effector functions of therapeutic IgG R Abès, JL Teillaud Pharmaceuticals 3 (1), 146-157, 2010 | 164 | 2010 |
CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells AR Mantegazza, MM Barrio, S Moutel, L Bover, M Weck, P Brossart, ... Blood 104 (4), 1183-1190, 2004 | 151 | 2004 |
Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. S Amigorena, D Choquet, JL Teillaud, H Korn, WH Fridman Journal of immunology (Baltimore, Md.: 1950) 144 (6), 2038-2045, 1990 | 148 | 1990 |
Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16 C De Romeuf, CA Dutertre, M Le Garff‐Tavernier, N Fournier, C Gaucher, ... British Journal of Haematology 140 (6), 635-643, 2008 | 146 | 2008 |
Molecular aspects of human FcγR interactions with IgG: functional and therapeutic consequences S Sibéril, CA Dutertre, C Boix, E Bonnin, R Ménez, E Stura, S Jorieux, ... Immunology letters 106 (2), 111-118, 2006 | 136 | 2006 |
FcγR: the key to optimize therapeutic antibodies? S Siberil, CA Dutertre, WH Fridman, JL Teillaud Critical reviews in oncology/hematology 62 (1), 26-33, 2007 | 128 | 2007 |
Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells N Jamin, L Miller, J Moncuit, WH Fridman, P Dumas, JL Teillaud Biopolymers: Original Research on Biomolecules 72 (5), 366-373, 2003 | 126 | 2003 |
FcγRII expression in resting and activated B lymphocytes S Amigorena, C Bonnerot, D Choquet, WH Fridman, JL Teillaud European journal of immunology 19 (8), 1379-1385, 1989 | 119 | 1989 |
Selection of a human anti-RhD monoclonal antibody for therapeutic use: Impact of IgG glycosylation on activating and inhibitory FcγR functions S Sibéril, C de Romeuf, N Bihoreau, N Fernandez, JL Meterreau, ... Clinical Immunology 118 (2-3), 170-179, 2006 | 116 | 2006 |